HSKA (US42805E3062)
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets.
MARKET: Nasdaq
Average yearly return: 38%
Outperformer
16Q2
Revenue Up 25% to $30 million; Earnings Per Share up 106% to $0.35
Average yearly return: 35%
Outperformer
Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $46.10 on HSKA shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $0.85 for the next fiscal quarter.
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets.
MARKET: Nasdaq
Fair value: $ 43.50
Discount: 12%Average yearly return: 38%
Outperformer
16Q2
Revenue Up 25% to $30 million; Earnings Per Share up 106% to $0.35
Fair value: $ 39.50
Discount: N/AAverage yearly return: 35%
Outperformer
Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $46.10 on HSKA shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $0.85 for the next fiscal quarter.
No comments:
Post a Comment